Literature DB >> 31469373

Synthesis and identification of heteroaromatic N-benzyl sulfonamides as potential anticancer agents.

Megan D Hopkins1, Felagot A Abebe1, Kristina A Scott1, Garett L Ozmer1, Alec A Sheir1, Lucas J Schroeder1, Robert J Sheaff1, Angus A Lamar1.   

Abstract

Sulfonamides are a crucial class of bioisosteres that are prevalent in a wide range of pharmaceuticals, however, the available methods for their production directly from heteroaryl aldehyde reagents remains surprisingly limited. A new approach for regioselective incorporation of a sulfonamide unit to heteroarene scaffolds has been developed and is reported within. As a result, a variety of primary benzylic N-alkylsulfonamides have been prepared via a two-step (one pot) formation from the in situ reduction of an intermediate N-sulfonyl imine under mild, practical conditions. The compounds have been screened against a variety of cell lines for cytotoxicity effects using a Cell Titer Blue assay. The cell viability investigation identifies a subset of N-benzylic sulfonamides derived from the indole scaffold to be targeted for further development into novel molecules with potential therapeutic value. The most cytotoxic of the compounds prepared, AAL-030, exhibited higher potency than other well-known anticancer agents Indisulam and ABT-751.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31469373     DOI: 10.1039/c9ob01694e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Development of a Rapid In Vitro Screening Assay Using Metabolic Inhibitors to Detect Highly Selective Anticancer Agents.

Authors:  Felagot A Abebe; Megan D Hopkins; Suraj N Vodnala; Robert J Sheaff; Angus A Lamar
Journal:  ACS Omega       Date:  2021-07-02

2.  Stimulation of Sulfonamides Antibacterial Drugs Activity as a Result of Complexation with Ru(III): Physicochemical and Biological Study.

Authors:  Paulina Spisz; Agnieszka Chylewska; Aleksandra Królicka; Sandra Ramotowska; Aleksandra Dąbrowska; Mariusz Makowski
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.